Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer

Hua Shen; Fang Zhu; Jinyuan Liu; Tongpeng Xu; Dong Pei; Rong Wang; Yingying Qian; Qi Li; Lin Wang; Zhumei Shi; Jitai Zheng; Qiudan Chen; Binghua Jiang; Yongqian Shu

doi:10.1371/journal.pone.0103305

Loading metrics

Open Access

Peer-reviewed

Research Article

Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer

Hua Shen ,

Contributed equally to this work with: Hua Shen, Fang Zhu

Affiliation Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Fang Zhu ,

Contributed equally to this work with: Hua Shen, Fang Zhu

Affiliation Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Jinyuan Liu,

Affiliation Department of Cardiothoracic Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Tongpeng Xu,

Affiliation Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Dong Pei,

Affiliation Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Rong Wang,

Affiliation Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Yingying Qian,

Affiliation Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Qi Li,

Affiliation Department of Pathology, Cancer Center, Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Lin Wang,

Affiliation Department of Pathology, Cancer Center, Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Zhumei Shi,

Affiliation Department of Pathology, Cancer Center, Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Jitai Zheng,

Affiliation Department of Pathology, Cancer Center, Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Qiudan Chen,

Affiliation Department of Pathology, Cancer Center, Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Binghua Jiang,

Affiliation Department of Pathology, Cancer Center, Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯
Yongqian Shu

* E-mail: shuyongqian1999@126.com

Affiliation Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China
⨯

Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer

Hua Shen,
Fang Zhu,
Jinyuan Liu,
Tongpeng Xu,
Dong Pei,
Rong Wang,
Yingying Qian,
Qi Li,
Lin Wang,
Zhumei Shi

Published: July 24, 2014
https://doi.org/10.1371/journal.pone.0103305

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.